News - UF Innovate

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury

UF Innovate | Accelerate graduate Oragenics, Inc. announced the submission of its Investigator’s Brochure (IB) application in preparation for its Phase II clinical trial using ONP-002 in Australia.

University of Florida Professor Explores Ways To Defend Against Deepfakes and Digital Scams

In this week’s Tech Tuesday, UF Innovate's host Bethany Gaffey meets Dr. Patrick Traynor, a professor in the Computer and Information Science and Engineering (CISE) department at the University of Florida.

Lifeward and MYOLYN Expand Partnership To Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward Ltd. and UF startup MYOLYN, Inc., are expanding their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use.

Artificial Intelligence Can Help Predict the Next Pandemic

UF researchers have published an algorithm capable of predicting which COVID-19 variant in circulation today is most likely to become dominant in the next three months.

Heralded Researcher Villanueva Alarcón Named New EEd Chair

UF researcher Idalis Villanueva Alarcón, Ph.D., has been named the new chair of the Department of Engineering Education at the Herbert Wertheim College of Engineering.

LightPath Technologies Expands Orlando Workforce Following $27M Acquisition

UF startup LightPath Technologies is expanding its workforce at its Orlando headquarters following a $27 million acquisition, underscoring its continued growth in next-gen optics and imaging systems.

Evergen Pushing the Boundaries of Tissue Engineering in Regenerative Medicine

Evergen, formerly known as UF startup RTI Surgical, is advancing innovative tissue engineering solutions in regenerative medicine.

UF College of Medicine’s 2024 NIH-Funded Research Makes an Impact in Neurological Disease, Cancer, Diabetes and More

UF researchers have led significant projects, funded by the National Institutes of Health, to enhance the lives of current and future patients affected by a wide range of medical conditions.

Myosin Therapeutics Closes Second Seed Round To Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies

UF startup Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding round, raising over $3 million to supplement significant investment from the National Institutes of Health.

Tech Tuesday: University of Florida Explores How Artificial Intelligence Can Help Medical Professionals

In this week’s Tech Tuesday, UF Innovate's host Bethany Gaffey introduces Dr. Elif Akçalı, an Associate Professor in the Department of Industrial and Systems Engineering at the University of Florida.

UF News